These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 877560)

  • 41. The binding of low molecular weight heparin to hemostatic enzymes.
    Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
    J Biol Chem; 1980 Nov; 255(21):10073-80. PubMed ID: 6448845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
    Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
    Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of human factor IX (Christmas factor).
    Di Scipio RG; Kurachi K; Davie EW
    J Clin Invest; 1978 Jun; 61(6):1528-38. PubMed ID: 659613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo correlation of clotting protease activity: effect of heparin.
    Gitel SN; Stephenson RC; Wessler S
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3028-32. PubMed ID: 268650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The activation of factor X evaluated by using synthetic substrates.
    Suomela H; Blombäck M; Blombäck B
    Thromb Res; 1977 Feb; 10(2):267-81. PubMed ID: 850910
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of the polyene antibiotic filipin on the lipid-dependent intrinsic pathway of blood coagulation.
    Van der Plas PM; Kraan L; Van Es G; Stibbe J; Hemker HC
    Haemostasis; 1974; 3(1):1-7. PubMed ID: 4435596
    [No Abstract]   [Full Text] [Related]  

  • 47. Blood coagulation: a cybernetic system.
    Seegers WH
    Ser Haematol; 1973; 6(4):549-78. PubMed ID: 4277382
    [No Abstract]   [Full Text] [Related]  

  • 48. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.
    Mertens K; Bertina RM
    Biochem J; 1984 Nov; 223(3):607-15. PubMed ID: 6334517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of human factor IXa by human antithrombin.
    Rosenberg JS; McKenna PW; Rosenberg RD
    J Biol Chem; 1975 Dec; 250(23):8883-8. PubMed ID: 1194266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a factor IX/IXa binding protein on the endothelial cell surface.
    Rimon S; Melamed R; Savion N; Scott T; Nawroth PP; Stern DM
    J Biol Chem; 1987 May; 262(13):6023-31. PubMed ID: 3032954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the generation and inhibition of factor Xa. Area under generation curves is independent of enzyme generation rate.
    Jesty J
    J Biol Chem; 1990 Oct; 265(29):17539-44. PubMed ID: 2211647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
    Kempton CL; Hoffman M; Roberts HR; Monroe DM
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel approach in potential anticoagulants from peptides epitope 558-565 of A2 subunit of factor VIII.
    Anastasopoulos C; Sarigiannis Y; Stavropoulos G
    Amino Acids; 2013 Apr; 44(4):1159-65. PubMed ID: 23299973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII).
    Pittman DD; Kaufman RJ
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2429-33. PubMed ID: 3128786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.
    London FS; Walsh PN
    Biochemistry; 2000 Aug; 39(32):9850-8. PubMed ID: 10933803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.